| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 79.15 Billion | USD 1123.11 Billion | 7.7% | 2023 |
FrequentlyAsked Questions
Diabetic shoes, also known as therapeutic footwear, are specially designed shoes or shoe inserts crafted to protect the feet of people with diabetes from common complications like skin breakdown, ulcers, and infections. These issues often arise due to peripheral neuropathy (nerve damage causing numbness), poor circulation, and reduced sensation in the feet, which can make everyday walking risky without proper support.
The major driver for the growth of the diabetes shoes market is the aging population and the rising prevalence of the disease globally. Moreover, as people are becoming more aware and health-conscious, the market is expected to grow at a rapid rate. Additionally, the rise in the role of e-commerce and brand expansion in diabetic footwear, the rise in research and development activities, and the increase in technological advancements and modernization in production techniques will further create new opportunities for the diabetic shoes market in the forecast period.
The global Diabetic Shoes Market was worth around USD 79.15 billion in 2023 and is estimated to grow to about USD 1123.11 billion by 2032
The CAGR value of the diabetic shoes market is expected to be around 7.7% during 2024-2032.
North America leads the global diabetic shoes market because of its massive aging population and large prevalence of type 1 and type 2 diabetes among the population, especially in the USA and Mexico, which eventually results in large consumption of such products in this region.
Some of the main competitors dominating the Diabetic Shoes Market include - Aetrex Worldwide, Inc., Podartis Srl., Etonic Worldwide LLC, Dr. Comfort, LLC., Advance Diabetic Solution, Apex Foot Health Industries LLC, Dr Zen Products, Inc., DARCO International, Inc, Orthofeet Inc., and Drew Shoe Corporation.
The report explores crucial aspects of the constrained peptide drugs market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients